LANTERN PHARMA INC. (LTRN) Free cash flow 2021–2025
LANTERN PHARMA INC. (LTRN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$15.7MFY2025 · since FY2021: -$10.6M → -$15.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.7M | +12.0% |
| FY2024 | -$17.8M | -24.1% |
| FY2023 | -$14.4M | -12.3% |
| FY2022 | -$12.8M | -20.6% |
| FY2021 | -$10.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More LTRN financial trends
LTRN RevenueLTRN Net incomeLTRN Net marginLTRN Gross profitLTRN Gross marginLTRN Operating incomeLTRN Operating marginLTRN Operating cash flowLTRN Capital expendituresLTRN Return on equityLTRN Stock buybacksLTRN Dividends paidLTRN Total assetsLTRN Total liabilitiesLTRN Shareholders’ equityLTRN overview →